Should You Buy Hudson Pacific Properties Inc (HPP) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Sell
Latest Price
8.700
1 Day change
-2.03%
52 Week Range
23.920
Analysis Updated At
2026/01/29
HPP is not a good buy right now for a beginner long-term investor who wants to put money to work immediately. The stock is in a clear bearish trend (weak moving averages and price below key pivot/resistance), the latest reported quarter still shows weakening revenue and deeply negative earnings, and Wall Street price targets have been getting cut. While insider/hedge-fund buying and a very low put/call open-interest ratio are constructive, they are not strong enough to outweigh the current downtrend and fundamental uncertainty heading into the next earnings (2026-02-26).
Technical Analysis
Trend/structure: Bearish. Moving averages are stacked negatively (SMA_200 > SMA_20 > SMA_5), signaling the longer-term trend is still down.
Momentum: RSI(6) is ~21.5 (oversold), which can support short bounces, but oversold alone is not a durable long-term entry signal.
MACD: Histogram slightly positive (~0.02) but contracting—suggests a fading bounce rather than a new uptrend.
Levels: Pivot 9.32 is overhead (current 8.69), so price is below a key decision level. Near-term support is S1 ~8.80 and S2 ~8.47; resistance levels are ~9.84 then ~10.17.
Pattern-based near-term probabilities provided: modest edge for a small next-day uptick, but negative bias over the next week.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): no signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Open interest put/call of 0.32 is call-heavy (bullish positioning), but the daily volume put/call of 0.93 is closer to neutral (only slightly more puts than calls by volume).
Volatility: Implied vol (30d) ~158% vs historical vol ~61% and high IV rank (~82) indicates the options market is pricing unusually large moves/uncertainty.
Activity: Today’s option volume is elevated vs the 30-day average (~125%), suggesting heightened speculation/hedging, but not a clean directional read.
Technical Summary
Sell
9
Buy
3
Positive Catalysts
on 2026-02-26 pre-market could re-rate the stock if the studio/office outlook improves.
Neutral/Negative Catalysts
Price trend is still bearish with overhead resistance near the 9.32 pivot and higher.
Fundamental uncertainty remains around recovery pace (especially studio business), reinforced by multiple recent analyst price-target cuts.
Very high implied volatility indicates the market expects large swings; this often coincides with unstable price action rather than a smooth long-term entry.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: 186.6M, down 6.87% YoY (top-line still shrinking).
Net income: -136.5M (still a large loss), though improved 39.37% YoY.
EPS: -2.12, worse YoY (down 56.29%).
Margin: Gross margin remains negative (reported -6.12), implying the underlying profitability picture is still challenged.
Overall: Some improvement in losses, but revenue contraction and negative earnings keep the long-term recovery thesis unproven.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: Analyst sentiment has become more cautious with a clear pattern of price-target reductions into early 2026. Notable actions include BMO downgrade to Market Perform and multiple Neutral ratings with lowered targets (Piper Sandler, Goldman, Mizuho, Citi). There are still a couple of bullish holdouts (BTIG Buy, Cantor Overweight), but the dominant direction recently is downward target revisions.
Wall Street pros: Potential value realization, improved macro for REITs, and a studio recovery narrative.
Wall Street cons: Uncertain timing/strength of studio recovery, limited near-term earnings growth, and continuing weak operating metrics reflected in lowered targets.
Influential/political trading: No recent congress trading data available; no politician activity provided.
Wall Street analysts forecast HPP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HPP is 15.44 USD with a low forecast of 11 USD and a high forecast of 26 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
Wall Street analysts forecast HPP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HPP is 15.44 USD with a low forecast of 11 USD and a high forecast of 26 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
7 Hold
1 Sell
Hold
Current: 8.880
Low
11
Averages
15.44
High
26
Current: 8.880
Low
11
Averages
15.44
High
26
Morgan Stanley
Ronald Kamdem
Underweight
downgrade
$14 -> $8
AI Analysis
2026-01-29
New
Reason
Morgan Stanley
Ronald Kamdem
Price Target
$14 -> $8
AI Analysis
2026-01-29
New
downgrade
Underweight
Reason
Morgan Stanley analyst Ronald Kamdem lowered the firm's price target on Hudson Pacific (HPP) to $8 from $14 and keeps an Underweight rating on the shares. Heading into earnings, the firm looked at office fundamental trends in Q4 in key REIT markets and said it expects elevated payout ratio to be a focus at SL Green Realty (SLG), Highwoods Properties (HIW) and American Assets Trust (AAT).
Goldman Sachs
Neutral
downgrade
2026-01-29
New
Reason
Goldman Sachs
Price Target
2026-01-29
New
downgrade
Neutral
Reason
Goldman Sachs lowered the firm's price target on Hudson Pacific to $14.50 from $16.50 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HPP
